Abstract
This study introduces a unique High-Performance Liquid Chromatography (HPLC) method for quantifying Metformin and Sesamol simultaneously in pharmaceuticals. The technique uses a reverse-phase C18 column with acetonitrile and water in a gradient pattern with UV detection. The method demonstrated good linearity for Metformin and Sesamol at concentrations ranging from 20-1.25 μg/ml, with coefficients of correlation (r²) of 0.9947 and 0.9908, respectively. The method demonstrated excellent repeatability, with precision measured as RSD below 2% for intra-day and inter-day measurements. The method's accuracy was proven through recovery tests. The Metformin's LOD and LOQ reported as 0.89 μg/mL & 2.71 μg/ml, and Sesamol's as 1.27 μg/ml & 3.86 μg/ml, respectively. The approach also demonstrated resilience to minor fluctuations in method parameters, making it suitable for regular analysis. This validated HPLC technique was successfully used for the simultaneous measurement of Metformin and Sesamol in a nanoliposomal formulation, providing a reliable tool for quality control.

This publication has 25 references indexed in Scilit: